Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 278 followers
Latest posts
Last updated about 9 hours ago
Human medicines European public assessment report (EPAR): Rivaroxaban Accord, rivaroxaban, Date of authorisation: 16/11/2020, Revision: 5, Status: Authorised
about 9 hours ago
Human medicines European public assessment report (EPAR): Rivaroxaban Accord, rivaroxaban, Date of...
Human medicines European public assessment report (EPAR): Zolgensma, onasemnogene abeparvovec, Date of authorisation: 18/05/2020, Revision: 20, Status: Authorised
about 9 hours ago
Human medicines European public assessment report (EPAR): Zolgensma, onasemnogene abeparvovec, Date of...
Human medicines European public assessment report (EPAR): Attrogy, diflunisal, Date of authorisation: 17/07/2025, Status: Authorised
about 9 hours ago
Human medicines European public assessment report (EPAR): Attrogy, diflunisal, Date of authorisation...
Human medicines European public assessment report (EPAR): Afinitor, everolimus, Date of authorisation: 02/08/2009, Revision: 32, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Afinitor, everolimus, Date of authorisation...
Human medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation: 30/05/2020, Revision: 13, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation...
Human medicines European public assessment report (EPAR): Icatibant Accord, icatibant, Date of authorisation: 16/07/2021, Revision: 2, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Icatibant Accord, icatibant, Date of...
Human medicines European public assessment report (EPAR): Nilotinib Accord, nilotinib, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Nilotinib Accord, nilotinib, Date of...
Human medicines European public assessment report (EPAR): Laventair Ellipta (previously Laventair), umeclidinium bromide,vilanterol, Date of authorisation: 08/05/2014, Revision: 21, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Laventair Ellipta (previously Laventair), umeclidinium...
Human medicines European public assessment report (EPAR): Roteas, edoxaban, Date of authorisation: 19/04/2017, Revision: 12, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Roteas, edoxaban, Date of authorisation...
Human medicines European public assessment report (EPAR): Lixiana, edoxaban, Date of authorisation: 19/06/2015, Revision: 21, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Lixiana, edoxaban, Date of authorisation...
Human medicines European public assessment report (EPAR): Kyntheum, brodalumab, Date of authorisation: 17/07/2017, Revision: 7, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Kyntheum, brodalumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Itovebi, inavolisib, Date of authorisation: 18/07/2025, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Itovebi, inavolisib, Date of authorisation...